

Cover Story
Free
By Matthew Bin Han Ong
Jill Biden stopped by at NCI earlier this week to reaffirm the Bidens' pledge to “fight cancer as we know it”—an early signal that cancer research is near the top of the national agenda at the Biden-Harris White House.
In Brief


Clinical Roundup


Drugs & Targets
NCI Trials


NCI Trials for February 2021
The National Cancer Institute approved the following clinical research studies last month.
Trending Stories
- An opportunity for Trump: Position U.S. cancer science to lead the world
- NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - In the Headlines: “There’s no one to stand up for NCI right now.”
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - Grilled by Congress, Kennedy defends NIH and NCI budget cuts, freezes, and RIFs
To avoid “offending” pharma, NCI doesn’t study the causes of early-onset colon cancer, HHS secretary incorrectly alleges - Trump administration is removing the mainstays of NCI and the federal government’s cancer program
Peer review, registries, and evidence-based patient information take a big hit